Dr. Feigin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
222 East 41st Street
13th Floor
New York, NY 10017- Is this information wrong?
Education & Training
- University of RochesterResidency, Neurology, 1989 - 1992
- New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1988 - 1989
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1988
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 1992 - 2025
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Clinical Trials
- Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) Start of enrollment: 2009 Sep 01
Publications & Presentations
PubMed
- 1 citationsSafety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study.Reilmann, R., Anderson, K., Feigin, A., Tabrizi, S., Leavitt, B., Stout, J., Piccini, P., Schubert, R., Loupe, P., Wickenberg, A., Borowsky, B., Rynkowski, G., Volkins...> ;The Lancet. Neurology. 2024 Mar 1
- 1 citationsArt therapy as a comprehensive complementary treatment for Parkinson's disease.Tom Ettinger, Marygrace Berberian, Ikuko Acosta, Alberto Cucca, Andrew Feigin, Danilo Genovese, Travis Pollen, Julianne Rieders, Rohita Kilachand, Clara Gomez, Girija ...> ;Frontiers in Human Neuroscience. 2023 Jan 1
- 24 citationsHuntington’s Disease: New Frontiers in TherapeuticsLing Pan, Andrew Feigin> ;Current Neurology and Neuroscience Reports. 2021 Feb 14
- Join now to see all
Press Mentions
- AAN 2023: Pridopidine Phase 3 Trial Misses Goal, but Benefits Seen for SomeMay 2nd, 2023
- Prilenia Shares Preliminary Topline Results from Phase 3 PROOF-HD Clinical Trial in Huntington's Disease and Data from Phase 2 HEALEY ALS Platform Trial of Pridopidine at the 75th American Academy of Neurology (AAN) Annual MeetingApril 25th, 2023
- Parkinson’s Cases May Be 50% Higher Than Previously Thought: Why That’s Important to KnowDecember 15th, 2022
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- NYU Langone HospitalsNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: